Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-08-002185
Filing Date
2008-01-29
Accepted
2008-01-29 16:30:58
Documents
1
Period of Report
2008-01-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 4098
  Complete submission text file 0001140361-08-002185.txt   6044
Mailing Address 2850 TELEGRAPH AVENUE SUITE 310 BERKELEY CA 94705
Business Address 2850 TELEGRAPH AVENUE SUITE 310 BERKELEY CA 94705 (510) 281-7700
Nile Therapeutics, Inc. (Issuer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O WEXFORD CAPITAL LLC 411 WEST PUTNAM AVE, SUITE 125 GREENWICH CT 06830
Business Address 203-862-7051
Mieyal Paul A (Reporting) CIK: 0001412471 (see all company filings)

Type: 4 | Act: 34 | File No.: 333-55166 | Film No.: 08558360